Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial
Boris Kovatchev, Laura Kollar, Stacey M. Anderson, et al.
The Lancet Digital Health (2020) Vol. 2, Iss. 2, pp. e64-e73
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Moshe Phillip, Revital Nimri, Richard M. Bergenstal, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 254-280
Open Access | Times Cited: 230
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
Marc D. Breton, Boris Kovatchev
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 9, pp. 601-608
Open Access | Times Cited: 186
The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study
Alessandro Bisio, Linda Gonder‐Frederick, Ryan McFadden, et al.
Journal of Diabetes Science and Technology (2021) Vol. 16, Iss. 3, pp. 663-669
Open Access | Times Cited: 57
Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards
Halis Kaan Aktürk, Shivani Agarwal, Lilian Hoffecker, et al.
Diabetes Care (2021) Vol. 44, Iss. 6, pp. e121-e123
Open Access | Times Cited: 57
Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis
Xiaojuan Jiao, Yunfeng Shen, Yifa Chen
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 2, pp. e002633-e002633
Open Access | Times Cited: 40
Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities
Peter G. Jacobs, Pau Herrero, Andrea Facchinetti, et al.
IEEE Reviews in Biomedical Engineering (2023) Vol. 17, pp. 19-41
Open Access | Times Cited: 34
Artificial Intelligence in Decision Support Systems for Type 1 Diabetes
Nichole S. Tyler, Peter G. Jacobs
Sensors (2020) Vol. 20, Iss. 11, pp. 3214-3214
Open Access | Times Cited: 68
Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
Julia Fuchs, Roman Hovorka
Expert Review of Medical Devices (2020) Vol. 17, Iss. 7, pp. 707-720
Open Access | Times Cited: 68
Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives
Korey K. Hood, Lori M. Laffel, Thomas Danne, et al.
Diabetes Technology & Therapeutics (2021) Vol. 23, Iss. 12, pp. 857-861
Open Access | Times Cited: 47
Sleep and diabetes‐specific psycho‐behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents
Alessandro Bisio, Sue A. Brown, Ryan McFadden, et al.
Pediatric Diabetes (2020) Vol. 22, Iss. 3, pp. 495-502
Open Access | Times Cited: 44
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Sue A. Brown, Roy W. Beck, Dan Raghinaru, et al.
Diabetes Care (2020) Vol. 43, Iss. 8, pp. 1822-1828
Open Access | Times Cited: 43
Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes
José García-Tirado, Leon S. Farhy, Ralf Nass, et al.
Diabetes Technology & Therapeutics (2022) Vol. 24, Iss. 7, pp. 461-470
Open Access | Times Cited: 22
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth G. Considine, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 15
Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials
Zige Fang, Mingyi Liu, Jun Tao, et al.
Journal of Endocrinological Investigation (2021) Vol. 45, Iss. 3, pp. 471-481
Closed Access | Times Cited: 30
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
Korey K. Hood, Natasha Garcia‐Willingham, Sarah J. Hanes, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2309-2318
Open Access | Times Cited: 21
Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms
Lía Nattero‐Chávez, Edurne Lecumberri Pascual, Esther de La Calle, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110627-110627
Closed Access | Times Cited: 11
A Data-Driven Approach to Classifying Daily Continuous Glucose Monitoring (CGM) Time Series
Benjamin J. Lobo, Leon S. Farhy, Mahdi Shafiei, et al.
IEEE Transactions on Biomedical Engineering (2021) Vol. 69, Iss. 2, pp. 654-665
Closed Access | Times Cited: 26
The physiological basis of insulin therapy in people with diabetes mellitus
Geremia B. Bolli, Francesca Porcellati, Paola Lucidi, et al.
Diabetes Research and Clinical Practice (2021) Vol. 175, pp. 108839-108839
Open Access | Times Cited: 20
Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
Su Lim Kang, Yoo Na Hwang, Ji Yean Kwon, et al.
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Patient‐reported outcomes for older adults on CamAPS FX closed loop system
Aika K. Schneider‐Utaka, Sarah J. Hanes, Charlotte K. Boughton, et al.
Diabetic Medicine (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 8
Evidence from clinical trials on high-risk medical devices in children: a scoping review
Kathrin Guerlich, Bernadeta Patro-Gołąb, Paulina Dworakowski, et al.
Pediatric Research (2023) Vol. 95, Iss. 3, pp. 615-624
Open Access | Times Cited: 8
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Viral N. Shah, Anne L. Peters, Guillermo E. Umpierrez, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 2
The closed‐loop artificial pancreas in 2020
Chiara Fabris, Boris Kovatchev
Artificial Organs (2020) Vol. 44, Iss. 7, pp. 671-679
Closed Access | Times Cited: 19
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial
Ahmad Haidar, Laurent Legault, Marie Raffray, et al.
Diabetes Technology & Therapeutics (2020) Vol. 23, Iss. 3, pp. 168-174
Open Access | Times Cited: 18
Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time
Boris Kovatchev, Benjamin J. Lobo
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. 8, pp. 519-528
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top